However, in cancer settings, TAMs upregulated the production of complement component C5a, which in turn binds its receptor (C5aR) on macrophages, resulting in M2-polarization and favouring CD8+ T cell inhibition and cancer progression [122]. The gene discussed is CD8A; the disease is cancer.